Three congressional committees advanced competing health care price transparency bills within two weeks of each other, and while all three keep the existing hospital and insurer disclosure framework intact, they split over a question that determines what patients would actually see before care.
The Senate Health, Education, Labor and Pensions Committee approved the Patients Deserve Price Tags Act by 21 to 1. The House Energy and Commerce Committee advanced the Lower Costs, More Transparency Act by 45 to 0. The House Ways and Means Committee approved the Health Care Price Certainty for All Americans Act on a 25 to 15 party-line vote. A fourth measure, the Prices on the Wall Act, cleared Energy and Commerce 24 to 21 and would require hospitals and surgery centers to physically post cash prices inside their facilities.
The disagreement worth understanding is about price estimator tools. Under current regulation, a hospital can satisfy its obligation to post prices for shoppable services by offering an online estimator rather than listing actual prices. The Ways and Means bill would keep that option. The Senate bill would phase estimators out and require real price listings. The Energy and Commerce bill is not explicit on the point.
The Rules Already on the Books
None of these bills creates price transparency from scratch, which is a common misreading.
Federal regulations already require hospitals to publish machine-readable files containing negotiated rates with insurers, discounted cash prices and billing codes, and to display prices for a set of shoppable services. Insurers must publish their own machine-readable files covering negotiated rates, out-of-network amounts and prescription drug prices. Current rules cap the shoppable services requirement at 300 items.
What the bills would do is write those requirements into statute, extend them to new settings and add enforcement. All three would expand disclosure to clinical laboratories, imaging centers and ambulatory surgical centers, direct the Department of Health and Human Services to standardize file formats so prices can be compared across settings, and impose escalating fines on repeat violators. All three would also require ownership disclosure by health care entities.
The two House bills additionally require insurers to disclose prior authorization metrics, administrative overhead relative to medical claims, and detailed encounter data, and would obligate pharmacy benefit managers to report rebates, administrative fees and contractual methodologies.
The Senate Bill Aims Squarely at the Patient
The Patients Deserve Price Tags Act, sponsored by Sen. Roger Marshall of Kansas and Sen. John Hickenlooper of Colorado, has the sharpest consumer focus of the three.
Its centerpiece is the advance explanation of benefits, a No Surprises Act provision that was enacted but never implemented because the industry lacks the standardized data exchange to deliver it. The bill would require insurers to give patients an advance estimate built from good-faith estimates transmitted by providers. If actual out-of-pocket costs substantially exceed that estimate, the patient would be held harmless for the excess unless the provider documents unforeseen medical circumstances.
The bill would also require providers to furnish a detailed itemized bill on request, with plain-language descriptions and billing codes for each item, plus information about charity care and language assistance. Providers deemed noncompliant with transparency provisions could not pursue extraordinary collection actions.
Marshall said patients deserve price tags, not surprise bills, and called the measure the only bipartisan health reform before Congress that could begin lowering costs immediately. Sen. Rand Paul of Kentucky cast the lone no vote, arguing the underlying problem is administratively fixed prices rather than a lack of disclosure.
Where the Industry Is Pushing Back
Hospital groups have concentrated their objections on the estimator question and on ownership reporting.
In comments to the Senate committee, the American Hospital Association argued that eliminating estimator tools would reduce patients' access to a familiar, consumer-friendly resource and disregard the significant investments hospitals have made building them. On ownership disclosure, the association said the requirement lacks a clearly defined scope and does not account for information hospitals already report, and that relying on a centralized federal source may give patients more consistent information.
Stakeholders have also warned that the advance explanation of benefits depends on transferring provider estimates to insurers at scale and in real time, which the industry cannot currently do because there is no standardized electronic data interchange for it.
Democratic opposition on the Ways and Means bill appears to have been partly about framing, since it was presented as implementing elements of a White House health plan announced earlier this year. Rep. Richard Neal of Massachusetts argued that advance explanations of benefits would serve patients better than pages of negotiated rates.
What Would Change for a Patient, and When
Nothing changes yet. Committee approval is an early step, and none of these bills has passed either chamber.
The realistic path is consolidation. The two House bills share enough provisions that a merged measure is plausible, and price transparency is widely expected to be a candidate for attachment to year-end health legislation, the vehicle such packages have typically used.
If a bill resembling the Senate version became law, the practical difference for a household would be receiving a cost estimate before a scheduled procedure and having recourse if the bill came in far higher. That is a meaningfully different experience from looking up a machine-readable file, which almost no patient does.
The caveat is implementation. The advance explanation of benefits has been law since the No Surprises Act passed and still does not exist in practice. Passing it a second time does not solve that.
Regulators are moving in parallel. In the proposed 2027 outpatient payment rule, CMS issued a request for information asking whether hospitals should disclose more about payer contracts, how machine-readable files could be standardized, and whether additional requirements could ensure posted pricing data is accurate rather than merely compliant.
For now, patients can still ask any hospital for a good-faith estimate before a scheduled service, which is already required for uninsured and self-pay patients under existing law.
Frequently Asked Questions
How many bills are we talking about? Three main transparency bills cleared three different committees, plus a separate House measure requiring hospitals to physically post cash prices inside facilities.
Do hospitals already have to post prices? Yes. Federal regulations already require machine-readable files with negotiated rates and cash prices, plus displayed prices for up to 300 shoppable services.
What is the main disagreement? Whether an online price estimator tool should satisfy the requirement to post prices for shoppable services, or whether hospitals must list actual prices.
What is an advance explanation of benefits? A cost estimate an insurer would send before a scheduled service. It was enacted in the No Surprises Act but has never been implemented because of data exchange limitations.
Has any of this become law? No. All three bills passed committee only. Neither chamber has voted.
What can a patient do right now? Request a good-faith estimate before a scheduled service. Uninsured and self-pay patients are already entitled to one under existing law.
When might Congress act? Price transparency is viewed as a candidate for year-end health legislation. No floor vote has been scheduled.
